PubRank

Mario Schiffer

Author PubWeight™ 71.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006 5.29
2 Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial. Lancet 2011 3.45
3 Pathogenesis and management of hypertension after kidney transplantation. J Hypertens 2011 2.66
4 Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ 2012 2.32
5 The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun 2012 1.88
6 Loss of podocyte aPKClambda/iota causes polarity defects and nephrotic syndrome. J Am Soc Nephrol 2009 1.86
7 Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol 2008 1.79
8 Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol 2007 1.75
9 Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. J Immunol 2003 1.74
10 Rapid screening of glomerular slit diaphragm integrity in larval zebrafish. Am J Physiol Renal Physiol 2007 1.63
11 Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes. Metabolism 2012 1.55
12 CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival. J Clin Invest 2011 1.49
13 Deficits in sialylation impair podocyte maturation. J Am Soc Nephrol 2012 1.47
14 ADAMTS13--marker of contractile phenotype of arterial smooth muscle cells lost in benign nephrosclerosis. Nephrol Dial Transplant 2010 1.44
15 A pocket guide to identify patients at risk for chronic kidney disease after liver transplantation. Transpl Int 2015 1.39
16 Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience. Nephrol Dial Transplant 2011 1.36
17 Novel regulators of kidney development from the tips of the ureteric bud. J Am Soc Nephrol 2005 1.33
18 Cofilin-1 inactivation leads to proteinuria--studies in zebrafish, mice and humans. PLoS One 2010 1.20
19 Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases. Nephrol Dial Transplant 2008 1.19
20 Glomerular epithelial cells in the urine: what has to be done to make them worthwhile? Am J Physiol Renal Physiol 2008 1.18
21 PKC alpha mediates beta-arrestin2-dependent nephrin endocytosis in hyperglycemia. J Biol Chem 2011 1.17
22 TbetaRI independently activates Smad- and CD2AP-dependent pathways in podocytes. J Am Soc Nephrol 2009 1.16
23 CIN85/RukL is a novel binding partner of nephrin and podocin and mediates slit diaphragm turnover in podocytes. J Biol Chem 2010 1.13
24 The balance of autocrine VEGF-A and VEGF-C determines podocyte survival. Am J Physiol Renal Physiol 2009 1.12
25 Deletion of protein kinase C-epsilon signaling pathway induces glomerulosclerosis and tubulointerstitial fibrosis in vivo. J Am Soc Nephrol 2007 1.07
26 B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE). Nephrol Dial Transplant 2009 1.06
27 Podocytic PKC-alpha is regulated in murine and human diabetes and mediates nephrin endocytosis. PLoS One 2010 1.01
28 An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor. PLoS One 2013 1.01
29 Leptin is a coactivator of TGF-beta in unilateral ureteral obstructive kidney disease. Am J Physiol Renal Physiol 2007 0.99
30 "Zebrafishing" for novel genes relevant to the glomerular filtration barrier. Biomed Res Int 2013 0.98
31 The podocyte as a direct target of immunosuppressive agents. Nephrol Dial Transplant 2010 0.98
32 PKC-alpha modulates TGF-beta signaling and impairs podocyte survival. Cell Physiol Biochem 2009 0.96
33 Back to the future: extended dialysis for treatment of acute kidney injury in the intensive care unit. J Nephrol 2010 0.95
34 CD2AP/CIN85 balance determines receptor tyrosine kinase signaling response in podocytes. J Biol Chem 2007 0.93
35 IGF-binding protein-3 modulates TGF-beta/BMP-signaling in glomerular podocytes. J Am Soc Nephrol 2006 0.93
36 Bone marrow-derived progenitor cells do not contribute to podocyte turnover in the puromycin aminoglycoside and renal ablation models in rats. Am J Pathol 2011 0.88
37 The role of metabolic and haemodynamic factors in podocyte injury in diabetes. Diabetes Metab Res Rev 2011 0.88
38 Renal involvement in preeclampsia: similarities to VEGF ablation therapy. J Pregnancy 2010 0.88
39 Circulating Angiopoietin-2 levels predict mortality in kidney transplant recipients: a 4-year prospective case-cohort study. Transpl Int 2014 0.85
40 aPKCλ/ι and aPKCζ contribute to podocyte differentiation and glomerular maturation. J Am Soc Nephrol 2013 0.85
41 Tyrosine phosphatase SHP-2 is a regulator of p27(Kip1) tyrosine phosphorylation. Cell Cycle 2008 0.85
42 Urinary NGAL Ratio Is Not a Sensitive Biomarker for Monitoring Acute Tubular Injury in Kidney Transplant Patients: NGAL and ATI in Renal Transplant Patients. J Transplant 2012 0.84
43 Genomic strategies for diabetic nephropathy. J Am Soc Nephrol 2003 0.84
44 Glomerular expression of transforming growth factor-beta (TGF-beta) isoforms in mice lacking CD2-associated protein. Pediatr Nephrol 2005 0.84
45 Neurologic manifestations of E coli infection-induced hemolytic-uremic syndrome in adults. Neurology 2012 0.83
46 Knockdown of the hypertension-associated gene NOSTRIN alters glomerular barrier function in zebrafish (Danio rerio). Hypertension 2013 0.83
47 CD2AP regulates SUMOylation of CIN85 in podocytes. Mol Cell Biol 2011 0.81
48 Serum with phospholipase A2 receptor autoantibodies interferes with podocyte adhesion to collagen. Eur J Clin Invest 2014 0.81
49 Urinary excretion of IGFBP-1 and -3 correlates with disease activity and differentiates focal segmental glomerulosclerosis and minimal change disease. Growth Factors 2010 0.79
50 The ADF/Cofilin-Pathway and Actin Dynamics in Podocyte Injury. Int J Cell Biol 2011 0.79
51 Podocalyxin-positive glomerular epithelial cells in urine correlate with a positive outcome in FSGS. J Nephrol 2012 0.79
52 Diminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathy. Am J Pathol 2011 0.78
53 Def-6, a novel regulator of small GTPases in podocytes, acts downstream of atypical protein kinase C (aPKC) λ/ι. Am J Pathol 2013 0.78
54 Corticosteroid-resistant nephrotic syndrome with focal and segmental glomerulosclerosis : an update of treatment options for children. Paediatr Drugs 2008 0.77
55 TGF-β/BMP pathways and the podocyte. Semin Nephrol 2012 0.77
56 Serum neutrophil gelatinase-associated lipocalin (NGAL) in patients with Shiga toxin mediated haemolytic uraemic syndrome (STEC-HUS). Thromb Haemost 2013 0.76
57 Circulating microRNAs in patients with Shiga-Toxin-producing E. coli O104:H4 induced hemolytic uremic syndrome. PLoS One 2012 0.76
58 Massive blood transfusion after the first cut in liver transplantation predicts renal outcome and survival. Langenbecks Arch Surg 2014 0.76
59 Rationale and design of the RIACT-study: a multi-center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with B-cell infiltrates in renal Transplant patients: study protocol for a randomized controlled trial. Trials 2012 0.75
60 Combination of everolimus with calcineurin inhibitor medication resulted in post-transplant haemolytic uraemic syndrome in lung transplant recipients--a case series. Nephrol Dial Transplant 2011 0.75
61 Overexpression of TGF-β Inducible microRNA-143 in Zebrafish Leads to Impairment of the Glomerular Filtration Barrier by Targeting Proteoglycans. Cell Physiol Biochem 2016 0.75